Skip to main content
. 2021 Nov 16;11:751209. doi: 10.3389/fonc.2021.751209

Figure 1.

Figure 1

Factors that may influence immune checkpoint inhibitor response in advanced EGFRm NSCLC. ICI, immune checkpoint inhibitor; TIL, tumor infiltrating lymphocyte; TMB, tumor mutational burden; PD-L1, programmed cell death 1 ligand. Figure created with BioRender.com.